News Source: Xtra News
| 6 months ago
Former Hollywood mogul David Geffen offered to buy the nearly 20-percent stake in The New York Times Co. held by a hedge fund but his overture was rebuffed, according to press reports on Tuesday. Fortune magazine said Geffen, a co-founder of...
News Source: Palm Beach Post
| 6 months ago
Entertainment billionaire David Geffen approached a hedge fund about buying its 19 percent stake in The New York Times Co., a person knowledgeable about the offer confirmed Tuesday. The fund, Harbinger Capital Partners, turned down the bid, according...
News Source: The Economic Times
| 6 months ago
Media mogul David Geffen tried to buy a stake in the New York Times Co from hedge fund Harbinger Capital Partners, but was rejected, a source with knowledge of the matter said on Monday. Geffen offered to buy the stake at market price, but Harbinger...
News Source: The Guardian
| 6 months ago
David Geffen, the music and film mogul, reportedly tried to buy a 19% stake in the New York Times Company. Last month, Geffen offered to buy the 19% stake in the New York Times Company owned by hedge fund Harbinger Capital Partners, according to...
News Source: Boston Herald
| 6 months ago
E pix strategy Epix Pharmaceuticals Inc. said it hired investment bank JPMorgan to help the Lexington-based biotech drug developer explore financing options and evaluate strategic alternatives, including a sale or merger. Epix said it needs to raise â...
News Source: Turks and Caicos Free Press
| 6 months ago
Media mogul David Geffen offered to buy a 19 percent stake in the New York Times Co held by hedge fund Harbinger Capital Partners but was rejected, a source with knowledge of the matter said on Monday...Harbinger fund manager Philip Falcone wanted a...